Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
NCT ID: NCT01255293
Last Updated: 2013-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2010-11-30
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of the Retinal Oxygen Saturaiton After Long-term Silicon Oil Tamponade
NCT02423382
Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma
NCT01460810
Scleral Buckling for Retinal Detachment Prevention in Genetically Confirmed Stickler Syndrome
NCT04465188
Silicone Effect on Corneal Endothelium and Corneal Biomechanics Using Corvis ST
NCT06861946
RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis Pigmentosa
NCT03629899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The retinal detachment will be repaired in a standard fashion. There will be no difference between the way retinal detachments are repaired in this study compared to those not in this study. Patients will be randomly assigned (like a flip of a coin) to receive one of the types of silicone oil. Both types of oil have very similar characteristics. The primary difference is that one type is thicker (more viscous) than the other, analogous to honey in comparison with maple syrup.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1000 centistoke silicone oil
1000 centistoke silicone oil
Patients who are enrolled in the study and have been identified to have a complex retinal detachment requiring silicone oil tamponade may be randomly assigned to receive 1000 centistoke silicone oil.
5000 centistoke silicone oil
5000 centistoke silicone oil
Patients who are enrolled in the study and have been identified to have a complex retinal detachment requiring silicone oil tamponade may be randomly assigned to receive 5000 centistoke silicone oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1000 centistoke silicone oil
Patients who are enrolled in the study and have been identified to have a complex retinal detachment requiring silicone oil tamponade may be randomly assigned to receive 1000 centistoke silicone oil.
5000 centistoke silicone oil
Patients who are enrolled in the study and have been identified to have a complex retinal detachment requiring silicone oil tamponade may be randomly assigned to receive 5000 centistoke silicone oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Judgment by the investigator that silicone oil tamponade is surgically indicated for appropriate repair of the complex retinal detachment.
* Visual acuity of light perception or better.
* Ability to provide written informed consent and comply with study assessments for the full duration of the study.
Exclusion Criteria
* Prior trabeculectomy or tube shunt surgery.
* Corneal opacity which limits visualization of the trabecular meshwork.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mid Atlantic Retina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mid Atlantic Retina
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason Hsu, MD
Role: PRINCIPAL_INVESTIGATOR
Mid Atlantic Retina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wills Eye Institute
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schwartz SG, Flynn HW Jr, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAR-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.